Paul B Manning's Net Worth

$337 Million

Estimate Recalculated Sep 17, 2025 09:46PM EST

Who is Paul B Manning

Paul B Manning has an estimated net worth of $337 Million. This is based on reported shares across multiple companies, which include Liquidia Corp, Verrica Pharmaceuticals Inc., Taysha Gene Therapies, Inc., Acumen Pharmaceuticals, Inc., AveXis, Inc., Candel Therapeutics, Inc., Dova Pharmaceuticals, Inc., Pasithea Therapeutics Corp., and PERRIGO CO.

SEC CIK

Paul B Manning's CIK is 0001494695

Past Insider Trading and Trends

2018 was Paul B Manning's most active year for acquiring shares with 20 total transactions. Paul B Manning's most active month to acquire stocks was the month of May. 2018 was Paul B Manning's most active year for disposing of shares, totalling 5 transactions. Paul B Manning's most active month to dispose stocks was the month of April. 2021 saw Paul B Manning paying a total of $14,410,287.67 for 1,822,087 shares, this is the most they've acquired in one year. In 2019 Paul B Manning cashed out on 12,979,016 shares for a total of $356,922,940.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Liquidia Corp

Investor
Updated Sep 16, 2024
Form 4
70.34%
337.08K
$8.90
$3.00M
Sep 16, 2024
6.60M
Purchase
Sep 12
Form 4
7.29%
20.36K
Jun 24, 2024
6.27M
Grant
Jun 20
Form 4
279.33K
$7.16
$2.00M
Dec 18, 2023
6.25M
Purchase
Dec 14
Form 4
20.00K
Jun 21, 2023
20.00K
Grant
Jun 19
Form 4
20.00K
Jun 22, 2022
20.00K
Grant
Jun 17
Form 4
435.67K
Apr 20, 2022
5.97M
Grant
Mar 31
Form 4
392.16K
$5.10
$2.00M
Apr 19, 2022
5.53M
Purchase
Apr 18
Form 4
20.00K
Sep 01, 2021
20.00K
Grant
Aug 20
Form 4
36.80%
198.41K
$2.52
$500.00K
Apr 15, 2021
5.14M
Purchase
Apr 13
Form 4
21.39K
Mar 26, 2021
21.39K
Grant
Mar 24
Form 4
30.00K
Nov 19, 2020
30.00K
Grant
Nov 18
Form 3
Nov 19, 2020
4.94M
Showing 12 results

Verrica Pharmaceuticals Inc.

Investor
Updated Jul 24, 2023
Form 4
2.61%
200.00K
$5.02
$1.00M
Jul 24, 2023
15.59M
Purchase
Jul 24
Form 4
53.57%
4.76M
$2.10
$10.00M
Jul 05, 2022
15.39M
Purchase
Jul 05
Form 4
0.62%
50.00K
$9.36
$467.91K
Dec 06, 2021
10.63M
Purchase
Dec 02 - Dec 03
Form 4
739.83K
$14.75
$10.91M
Mar 29, 2021
10.58M
Purchase
Mar 25
Form 4
0.25%
20.00K
$9.09
$181.80K
Aug 21, 2020
9.84M
Purchase
Aug 20
Form 4
0.68%
10.00K
$8.55
$85.50K
Aug 19, 2020
9.82M
Purchase
Aug 18
Form 4
0.41%
6.00K
$6.92
$41.52K
Aug 18, 2020
9.81M
Purchase
Aug 17
Form 4
12.12%
158.50K
$6.44
$1.02M
Aug 17, 2020
9.80M
Purchase
Aug 13 - Aug 14
Form 4
0.26%
20.89K
$14.38
$300.28K
Oct 10, 2019
9.64M
Purchase
Oct 08 - Oct 10
Form 4
0.51%
47.50K
$11.17
$530.81K
Jan 07, 2019
9.62M
Purchase
Jan 07
Form 4
0.76%
70.20K
$14.15
$993.02K
Nov 14, 2018
9.57M
Purchase
Nov 12 - Nov 13
Form 4
3.35%
300.00K
$15.00
$4.50M
Aug 15, 2018
9.50M
Purchase
Jun 19
Form 4
0.43%
33.00K
$15.08
$497.64K
Aug 14, 2018
9.20M
Purchase
Aug 10
Form 4
Jun 19, 2018
9.17M
Options
Jun 19
Form 3
Jun 14, 2018
27.34K
Showing 15 results

Taysha Gene Therapies, Inc.

Investor
Updated Jul 01, 2024
Form 4
1.33M
$2.25
$3.00M
Jul 01, 2024
24.85M
Purchase
Jun 27
Form 4
0.61%
100.00K
$1.63
$163.00K
Nov 20, 2023
23.52M
Purchase
Nov 17
Form 4
16.47M
$0.90
$14.82M
Aug 16, 2023
23.42M
Purchase
Aug 16
Form 4
1,054.84%
1.50M
$2.00
$3.00M
Nov 02, 2022
6.95M
Purchase
Oct 31
Form 4
15.50K
Jun 22, 2022
15.50K
Grant
Jun 17
Form 4
4.89%
201.60K
$7.80
$1.57M
Feb 04, 2022
7.52M
Purchase
Feb 02 - Feb 03
Form 4
6.88%
2.20K
$13.19
$29.04K
Nov 29, 2021
5.25M
Purchase
Nov 24
Form 4
166.67%
20.00K
$12.54
$250.80K
Nov 24, 2021
5.25M
Purchase
Nov 23
Form 4
15.50K
Jun 21, 2021
15.50K
Grant
Jun 17
Form 4
12.00K
$20.98
$251.76K
May 17, 2021
5.23M
Purchase
May 14
Form 4
8.95%
435.00K
Sep 30, 2020
5.30M
Options
Sep 28
Form 4
31.00K
Sep 25, 2020
31.00K
Grant
Sep 23
Form 3
Sep 23, 2020
Showing 13 results

Acumen Pharmaceuticals, Inc.

Investor
Updated Jul 08, 2021
Form 4
8.45%
312.50K
$16.00
Jul 08, 2021
4.01M
Purchase
Jul 06
Form 3
Jun 30, 2021
89.71K
Showing 2 results

AveXis, Inc.

Investor
Updated May 15, 2018
Form 4
-100.00%
-1.73M
May 15, 2018
Disposition
May 15
Form 4
1.76%
4.01K
Mar 30, 2018
1.46M
Grant
Mar 13
Form 4
2.45K
Jun 01, 2017
2.45K
Grant
May 30
Form 4
-19.44%
-289.86K
$34.50
-$10.00M
Sep 15, 2016
1.45M
Sale
Sep 13
Form 4
Feb 19, 2016
2.18M
Options
Feb 17
Form 4
26.50K
Feb 12, 2016
26.50K
Grant
Feb 10
Form 3
Feb 10, 2016
243.53K
Showing 7 results

Candel Therapeutics, Inc.

Investor
Updated Jun 27, 2024
Form 4
14.24K
Jun 27, 2024
14.24K
Grant
Jun 26
Form 4
14.24K
Jun 29, 2023
14.24K
Grant
Jun 28
Form 4
14.24K
Oct 17, 2022
14.24K
Grant
Oct 13
Form 4/A
-5.59%
-172.46K
$8.00
$13.00M
Aug 04, 2021
2.91M
Buy-Options
Jul 29
Form 4
-59.31%
-1.80M
Aug 02, 2021
1.29M
Options
Jul 29
Form 4
56.00K
$7.34
$410.78K
Jul 29, 2021
56.00K
Purchase
Jul 27 - Jul 29
Form 3
Jul 26, 2021
Showing 7 results

Dova Pharmaceuticals Inc.

Investor
Updated Nov 12, 2019
Form 4
-100.00%
-14.76M
$27.50
-$405.96M
Nov 12, 2019
Disposition
Nov 12
Form 4
0.22%
28.06K
$15.87
$445.34K
Aug 12, 2019
14.76M
Purchase
Aug 09
Form 4
0.53%
68.00K
$7.48
$508.64K
Mar 08, 2019
14.73M
Purchase
Mar 07
Form 4
1.01%
128.50K
$6.48
$832.05K
Dec 21, 2018
14.67M
Purchase
Dec 21
Form 4
2.14%
266.63K
$6.17
$1.65M
Dec 20, 2018
14.54M
Purchase
Dec 20
Form 4
0.22%
27.00K
$28.42
$767.38K
Jun 08, 2018
14.27M
Purchase
Jun 06 - Jun 07
Form 4
0.97%
120.00K
$26.17
$3.14M
Jun 06, 2018
14.24M
Purchase
Jun 04 - Jun 05
Form 4
Nov 13, 2017
14.12M
Acq/Dis
Nov 09
Form 4
25.87%
25.87K
$22.30
$576.87K
Aug 17, 2017
14.12M
Purchase
Aug 15 - Aug 16
Form 4
8.65%
150.00K
$17.00
$2.55M
Jul 07, 2017
14.10M
Purchase
Jul 05
Form 3
Jun 28, 2017
13.95M
Showing 11 results

Pasithea Therapeutics Corp.

Investor
Updated Feb 14, 2023
Form 3
Feb 14, 2023
2.61M
Showing 1 results

PERRIGO CO

EVP & General Manager, PBM
Updated Jun 22, 2010
Form 3
Jun 22, 2010
Showing 1 results